
Tissue-research peptides
Ara-290
Lyophilized Ara-290, unreconstituted. It is a peptide discussed in preclinical tissue-signaling research.
Also searched as: cibinetide, ARA290
10 mg
€42.99
- Amount
- 10 mg, 16 mg
- Storage
- −20 °C · dry · dark
- COA
- Supplier certificate pending
About this material
Ara-290 is supplied by Rierink Compounds as a laboratory research material. Made in Europe. It is a peptide discussed in preclinical tissue-signaling research. It sits with the peptides studied in laboratory research on tissue-signaling pathways. The material is a lyophilized powder and is supplied unreconstituted. The companion reagent listed for it is BAC water. Store at −20 °C, dry and protected from light. For laboratory research use only. Not a medicine. Not for human or veterinary use. Rierink does not publish reconstitution volumes, dosing, or administration guidance.
Research context
Ara-290. It is a peptide discussed in preclinical tissue-signaling research.
Published studies describe a research material and a study design. They are not a protocol for this vial, not a dose, and not a permission for human or veterinary use.
Recommended reagent
This is the laboratory reagent listed with this lyophilized material.
Certificates
These certificates come from our supplier and relate to the supplier's batches. They are not Rierink's own independent tests of the exact vial you receive. Every Rierink vial carries our own internal lot number, and independent testing of our own lots is underway; results will be published per lot. We welcome independent testing: any customer or lab is free to test our products, and we're happy to share results sent to us.
Supplier certificate pending
Research briefings
- Published Reports on Ara-290Indexed cell, animal, and limited clinical papers describe Ara-290 as a synthetic innate-repair-receptor peptide studied for small-fiber and inflammatory readouts, distinct from the injury-model and thymic peptides already briefed, and thos
- Published Reports on ARA-290 (Cibinetide)Indexed papers reported ARA-290 (cibinetide) findings in small clinical neuropathy studies in sarcoidosis and type 2 diabetes patients and in related preclinical models. Each summary states the study type and a limitation. Reporting a human trial is not guidance to use the research material. [ARA-290](/compounds/ara-290) is for laboratory research only.
Trustpilot
A small laboratory is built one honest sentence at a time.
We're new on Trustpilot and don't have any reviews yet. Be one of the first to share your experience.
We are still the company that picks up the phone. The next researcher finds us because someone wrote down what actually happened: the lot that matched the label, the parcel that arrived late, the reply that took a day too long. That public record is how a young lab earns a name.
Write the first review